Cambium Analytica is a biotechnology startup founded in 2019 and headquartered in the United States. The company positions itself as a full-service provider of analytical testing, product research & development, and QA/QC services within the biotechnology industry. Cambium specializes in natural products such as natural foods, dietary supplements, botanical products, and natural pharmaceuticals.
Despite its recent establishment, Cambium Analytica has not disclosed any last investment details or involved investors as of now. The company's focus on the burgeoning natural products sector presents potential opportunities for growth and innovation within the biotechnology landscape. With its comprehensive range of services, Cambium Analytica aims to carve a niche in the market and contribute to the development of high-quality natural products.
There is no investment information
No recent news or press coverage available for Cambium Analytica.